Clinical Trials Logo

Spinocerebellar Ataxias Type 6 clinical trials

View clinical trials related to Spinocerebellar Ataxias Type 6.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01811706 Completed - Clinical trials for Spinocerebellar Ataxias Type 2

Dalfampridine and Gait in Spinocerebellar Ataxias

Start date: February 2013
Phase: N/A
Study type: Interventional

Investigators expect there will be improvement in walking speed and steadiness after taking Dalfampridine, thereby improving activities of daily living and enhancing social and occupational functions for patients with spinocerebellar ataxia.